UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 14A

PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

  Preliminary Proxy Statement
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material Under §240.14a-12

QUORUM HEALTH CORPORATION

(Name of Registrant as Specified in its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
  (1)  

Title of each class of securities to which transaction applies:

 

     

  (2)  

Aggregate number of securities to which transaction applies:

 

     

  (3)  

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

     

  (4)  

Proposed maximum aggregate value of transaction:

 

     

  (5)  

Total fee paid:

 

     

  Fee paid previously with preliminary materials.
  Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
  (1)  

Amount Previously Paid:

 

     

  (2)  

Form, Schedule or Registration Statement No.:

 

     

  (3)  

Filing Party:

 

     

  (4)  

Date Filed:

 

     

 

 

 


LOGO

Important Notice Regarding the Availability of Proxy Materials for the Shareholder Meeting

to be held on May 31, 2019, for Quorum Health Corp.

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. To view the proxy statement and annual report, go to www.proxydocs.com/QHC . To submit your proxy while visiting this site, you will need the 12 digit control number in the box below.

 

         Under United States Securities and Exchange
             Commission rules, proxy materials can be
         distributed by making them available on the Internet. We have chosen to use these procedures for our 2019 Annual Meeting and need YOUR participation.
         If you want to receive a paper or e-mail copy of the
             proxy materials, you must request one. There is
         no charge to you for requesting a copy. In order to receive a paper package in time for this year’s annual meeting, please make this request on or before May 21, 2019.

 

LOGO  

 

For a Convenient Way to VIEW Proxy Materials

– and –

VOTE Online go to: www.proxydocs.com/QHC

 

   LOGO

Proxy Materials Available to View or Receive:

1. Proxy Statement     2. Annual Report

Printed materials may be requested by one of the following methods:

 

 

LOGO

INTERNET

www.investorelections.com/QHC   

 

   

 

LOGO

TELEPHONE

(866) 648-8133

 

       

 

LOGO

*E-MAIL

paper@investorelections.com

 

 

You must use the 12 digit control number

located in the shaded gray box below.

    

 

*  If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting material.

 

 

      

ACCOUNT NO.

     SHARES   

 

 

Company Notice of Annual Meeting

 

LOGO   Date:    Friday, May 31, 2019
  Time:    8:00 AM (Local Time)
  Place:    Salon A - Hilton Garden Inn, 9150 Carothers Parkway, Franklin, TN, 37067

The purpose of the Annual Meeting is to take action on the following proposals:

The Board of Directors recommends that you vote “FOR” the following.

 

1.    To elect nine nominees for director of the Company, nominated by the Board of Directors, with each director to serve until the 2020 annual meeting of the stockholders of the Company and until his or her successor is elected and qualified;
   Nominees    01    Terry Allison Rappuhn    04 Jon H. Kaplan       07 Alice D. Schroeder
      02    Robert H. Fish    05 Barbara R. Paul, M.D.       08 R. Lawrence Van Horn, Ph.D.
      03    Joseph A. Hastings, D.M.D.    06 William Paul Rutledge      
The Board of Directors recommends that you vote “FOR” the following.
2.    To approve the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan;
3.    To approve the Quorum Health Corporation 2018 Restricted Stock Plan;
4.    To approve, in an advisory (non-binding) vote, the compensation of the Company’s named executive officers, as more fully described in the accompanying proxy statement (“say-on-pay”); and
5.    To ratify the appointment of Deloitte & Touche, LLP as our independent registered public accounting firm for the year ending December 31, 2019.
NOTE : In their discretion, the proxies are authorized to vote upon such other business as may properly come before the meeting or any postponement or adjournment of the meeting.
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Quorum Health Charts.
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Quorum Health Charts.